Jazz Pharmaceuticals plc revenue for the last year amounted to 3.83 B USD, the most of which — 3.83 B USD — came from its highest performing source at the moment, Pharmaceutical Products, the year earlier bringing 3.66 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Jazz Pharmaceuticals plc 3.49 B USD, and the year before that — 3.37 B USD.